. Feb 19, 2021 1:07 PM PST. Virpax Pharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Virpax Pharmaceuticals stock? Buy immediately with a market order or use a limit order to delay your purchase until Virpax Pharmaceuticals reaches your desired price. CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION . Virpax’s MMS019 Reduced Nasal and Brain Viral Load in Animal Study BusinessWire - BZX. The company belongs in the Biotechnology industry, Healthcare sector and … The company was founded by Anthony P. Mack on May 12, 2017 and and is … SCoRE: 63 . With Virpax Pharmaceuticals stock trading at $6.45 per share, the total value of Virpax Pharmaceuticals stock (market capitalization) is $29.08M. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Virpax Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Virpax Pharmaceuticals's VRPX shares and potentially its market environment have … $4.3301. Virpax Pharmaceuticals' lock-up period expires on Monday, August 16th. Virpax Pharmaceuticals had issued 1,800,000 shares in its initial public offering on February 17th. The total size of the offering was $18,000,000 based on an initial share price of $10.00. Virpax Pharmaceuticals stock was originally listed at a price of $6.53 in Feb 17, 2021. VIRPAX PHARMACEUTICALS, INC. Buy. View VRPX historial stock data and compare to other stocks and exchanges. The company’s stock price has collected 7.95% of gains in the last five trading sessions. The major determining factor in this rating is whether the stock is trading close to its 52-week-high. WEST CHESTER, PA / ACCESSWIRE / February 19, 2021 / Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the closing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross … Virpax Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations. Find out which indices include the Virpax Pharmaceuticals Inc stock. Virpax Pharmaceuticals Inc Stock Ownership Add to Watchlist. View Virpax Pharmaceuticals stock trends here About VRPX Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Virpax Pharmaceuticals is now publicly available to trade under the ticker symbol VRPX . February 19, 2021 - 4:07 pm. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). The current P/S ratio for Virpax Pharmaceuticals as of May 19, 2021 is . Data is currently not available. Access our live advanced interactive Virpax Pharmaceuticals Inc stock chart. Stock Price Prediction: Update at 5:00pm EST FRIDAY. NASDAQ 1.10%. Trending now. VIRPAX PHARMACEUTICALS, INC. Pursuant to Section 242 of the General Corporation Law of the State of Delaware, Virpax Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: 1. Learn about the SCoRE. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is registered under the ticker NASDAQ:VRPX . Virpax Pharmaceuticals, Inc. Common Stock, also called Virpax Pharmaceuticals, is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Trading. 10/09/2020. Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. virpax(r) pharmaceuticals announces pricing of initial public offering.announced pricing of ipo of 1.8 million shares of its common stock at a public offering price of $10.00 per share. Its products include Epoladerm, OSF200, Probudur, NES100, PES200 and MMS019. Virpax Pharmaceuticals Inc. advanced stock charts by MarketWatch. The relative strength of a dividend stock indicates whether the stock is uptrending or not. VRPX is DOWN -31% since the begininning of the year. Free forex prices, toplists, indices and lots more. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) went up by 1.00% from its latest closing price compared to the recent 1-year high of $8.24. However, action by the FDA has been deferred due to COVID-19. UBX1325 Phase 1 initial data expected 1H 2021. SEC Filings provided by EDGAR Online, Inc. Prev Page Next Page. Covers 1,009,505 shares of common stock issuable under the Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan (the “2017 Plan”). Topical metered-dose spray. VRPX updated stock price target summary. Monday, April 05, 2021. Research its history to confirm it's a solid investment against your financial goals. Free forex prices, toplists, indices and lots more. Find the latest Virpax Pharmaceuticals, Inc. (VRPX) stock discussion in Yahoo Finance's forum. 09:00 AM ET. Their stock opened with $10.00 in its Feb 16, 2021 IPO. Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. LAST PRICE - 02:40pm VRPX is trading DOWN -$-0.25 or -5.3% from yesterday's close of $4.75. Virpax Pharmaceuticals, Inc. Common Stock, also called Virpax Pharmaceuticals, is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. 2.12 “Common Stock” means the Company’s Common Stock, par value $0.00001 per share. Here's how you can invest. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Contact Email Info@virpaxpharma.com. OF. Services. SEC Filings for Virpax Pharmaceuticals Inc. View institutional ownership trends for Virpax Pharmaceuticals. Virpax Pharmaceuticals (NASDAQ:VRPX) and Galmed Pharmaceuticals (NASDAQ:GLMD) are both small-cap medical companies, but which is the superior stock?We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings. The company’s stock price has collected 12.53% of gains in the last five trading sessions. Sell. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. This page contains information on users’ sentiments for the Virpax Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table. View today's stock price, news and analysis for Virpax Pharmaceuticals Inc. (VRPX). Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. Poziotinib Phase 2 cohort 3 data did not meet primary endpoint – 12/22/20. Let’s start up with the current stock price of Virpax Pharmaceuticals Inc. (VRPX), which is $5.14 to be very precise. The Stock rose vividly during the last session to $6.00 after opening rate of $4.63 while the lowest price it went was recorded $4.50 before closing at $4.62. Their latest funding was raised on Feb 16, 2021 from a Series C round. Press Release reported 1 hour ago that Virpax Announces Results of Probudur(TM) in Animal Study. Its products include DSF100, Probudur, Epoladerm and NES100. ACCESSWIRE +5.74%. Find the latest Virpax Pharmaceuticals, Inc. (VRPX) stock quote, history, news and other vital information to help you with your stock trading and investing. Nasdaq 100. Virpax Pharmaceuticals Inc. (VRPX) registered a 1.00% upside in the last session and has traded in the green over the past 5 sessions. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. Real-time exchange rate quote of VIRPAX PHARMACEUTICALS INC. - COMMON STOCK including detailed information, live chart and news, profile and other market data. Financials. Company information for Virpax Pharmaceuticals Inc USD0.00001 share priceincluding general stock details, key personnel and important dates for your diary. Other Notable StockTweets About VRPX. Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania. Rolontis PDUFA date was 10/24/20. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Get the hottest s The stock’s 5-day price performance is 7.95%, and it has moved by 19.35% in 30 days. Monday, April 19, 2021. Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. Stock quote and company snapshot for VIRPAX PHARMACEUTICALS INC (VRPX), including profile, stock chart, recent news and events, analyst opinions, and research reports. PRICE ACTION $4.50. The current price to book ratio for Virpax Pharmaceuticals as of May 28, 2021 is 2.37. Virpax Pharmaceuticals, Inc. is a biopharmaceutical company. Free forex prices, toplists, indices and lots more. Virpax Pharmaceuticals Engages Torreya Capital to Advise on Global Partnering Efforts BusinessWire - BZX. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross … documents---0.0012590885162354. Their stock opened with $10.00 in its Feb 16, 2021 IPO. Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals is a preclinical stage biopharmaceutical company focused on becoming a global leader in pain management by developing and delivering innovative non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. A high-level overview of Virpax Pharmaceuticals, Inc. (VRPX) stock. The Virpax Pharmaceuticals, Inc. stock price fell by -0.74% on the last day (Thursday, 17th Jun 2021) from $4.08 to $4.05.During the day the stock fluctuated 6.91% from a day low at $4.05 to a day high of $4.33.The price has been going up and down for this period, and there has been a -7.95% loss for the last 2 weeks. Check if VRPX has a Buy or Sell Evaluation. 2.13 “Company” means Virpax Pharmaceuticals, Inc., a Delaware corporation, and any successor thereto as provided in Section 16.8. View Virpax Pharmaceuticals, Inc. VRPX investment & stock information. Virpax has licensed a patented metered-dose spray system that delivers active pharmaceutical ingredients (API). Ticker: VRPX. Commissions Margin Rates Interest Rates Research and News Market Data Stock Yield Enhancement Program Other Fees. +0.2801 (+6.92%) DATA AS OF Jun 16, 2021 11:14 AM ET. Mr. Virpax Pharmaceuticals, Inc. (the “Registrant”) hereby incorporates by reference the description of its common stock, par value $0.00001 per share, to be registered hereunder contained under the heading “Description of Securities” in the Registrant’s Registration Statement on Form S-1 (File No. (VRPX) raised $15 million in an initial public offering (IPO) on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO. VRPX: Get the latest Virpax Pharmaceuticals stock price and detailed information including VRPX news, historical charts and realtime prices. With your account you will as well have access to charting tools, advanced order types, leveraged trading and 24-hour global client support. The company is focused on developing pharmaceutical product candidates for pain management. Search for Virpax Pharmaceuticals. Sorrento said it learned of Virpax through documents it filed with the Securities and Exchange Commission after the company completed a small initial public stock … Overview Earnings Dividend Ownership. For financial reporting, their fiscal year ends on December 31st. Top institutional investors include HN Saltoro Capital LP (0.55%). Virpax Pharmaceuticals' stock is owned by many different retail and institutional investors. VRPX 4.50 0.25 (5.26%) After your fiat currency strikes your account, you will be able to buy stock from Williams Companies (WMB). Purchase now or later. One share of VRPX stock can currently be purchased for approximately $3.97. How much money does Virpax Pharmaceuticals make? Virpax Pharmaceuticals has a market capitalization of $19.63 million. N/A. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. Virpax will utilize our drug delivery technologies to develop a pipeline of proprietary prescription candidates for commercialization. Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. VIRPAX PHARMACEUTICALS, INC. : News, information and stories for VIRPAX PHARMACEUTICALS, INC. | Nasdaq: VRPX | Nasdaq Virpax Pharmaceuticals Announces Closing of Initial Public Offering. ACCESSWIRE +5.74%. Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Nasdaq Listed. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) loss -5.26% – Is It right time to buy? Virpax Pharmaceuticals Announces Closing of Initial Public Offering. Virpax Announces Results of Probudur(TM) in Animal Study ACCESSWIRE. WEST CHESTER, PA / ACCESSWIRE / February 19, 2021 / Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in … S-1. This proprietary spray formulation delivers the API as a film and may lead to adhesion capabilities superior to those of transdermal patches, while maintaining comparable skin absorption capabilities to transdermal patches currently on the market. Anthony P. Mack has more than 25 years of experience in the pharmaceutical and finance industries. The stock spiked 1.00% in intraday trading to $4.75 this Thursday, 06/10/21, hitting a weekly high. Get the latest Virpax Pharmaceuticals Inc (VRPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. DOW 0.03%. Registration Statement. The Stock rose vividly during the last session to $5.22 after opening rate of $4.376 while the lowest price it went was recorded $4.2649 before closing at $4.41. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Insider buying vs selling Have Virpax Pharmaceuticals Inc insiders been buying or selling? April 9, 2021 Let’s start up with the current stock price of Virpax Pharmaceuticals Inc. (VRPX), which is $6.00 to be very precise. Virpax Pharmaceuticals, Inc. engages in developing pharmaceutical products for pain management by using new drug delivery systems. Virpax Pharmaceuticals, Inc. 1055 Westlakes Drive, Suite 300 Berwyn, PA 19312 610.727.4597 info@virpaxpharma.com JUN 11 02:40:13pm VRPX. Historical PS ratio values for Virpax Pharmaceuticals (VRPX) over the last 10 years. Selected key stats of Virpax Pharmaceuticals, Inc. (VRPX) including 10 year stock price and latest news. Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Virpax Pharmaceuticals (VRPX) stock price, charts, trades & the US's most popular discussion forums. Virpax Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Company profile page for Virpax Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information Thani Jambulingam: Director: 2021-02-17: 100: Their latest funding was raised on Feb 16, 2021 from a Series C round. Phone Number 610.727.4597. February 16, 2021 - 7:45 pm. Get the latest Virpax Pharmaceuticals, Inc. VRPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax ® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, … Virpax Pharmaceuticals Inc 4.50 0.25 (5.26%) Virpax Pharmaceuticals Inc OTC Updated Jun 11, 2021 4:44 PM. VRPX Virpax Pharmaceuticals Inc — Stock Price and Discussion | Stocktwits. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) went up by 12.44% from its latest closing price compared to the recent 1-year high of $8.24. Virpax Pharmaceuticals, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. BERWYN, Pa.--(BUSINESS WIRE)-- Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments.“We successfully completed our initial public offering (IPO) of 1,800,000 shares of our common stock in mid-February and immediately began our IND enabling … Share your opinion and gain insight from other stock traders and investors. Please refer to the Stock Price Adjustment Guide for more information on our historical prices. New Stock: Look Up. Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the results of an animal study model for MMS019, its anti-viral product candidate for respiratory viruses. By Noah Smith June 14, 2021 How have the shares performed? Virpax Pharmaceuticals (VRPX) stock price, charts, trades & the US's most popular discussion forums. Right now VRPX is $0.50 below high of day. Platforms APIs Margin Products Order Types Securities Financing Features in Focus Probability Lab Exchange Listings Sustainable Investing. Add to … Overview. VRPX Stock Price (NASDAQ), Score, Forecast, Predictions, and Virpax Pharmaceuticals, Inc. News. This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee The current RSI for VRPX stock in for the last two-week period is set at 58.51, with the RSI for the last a single of trading hit 66.87, and the three-weeks RSI is set at 53.13 for Virpax Pharmaceuticals Inc. [VRPX], while it was recorded at 5.08 for the last single week of trading. Schumacher 750 Watt Power Inverter Manual, Used Industrial Ice Machines, Big South Baseball Standings 2021, Puff Pastry Pies Chicken, Johnson And Johnson Vaccine Appointment Las Vegas, Her Majesty The King Hatshepsut, Adidas Field Hockey Sticks For Forwards, Pensacola Bay Center Seating Capacity, " />

virpax pharmaceuticals stock

by | Jun 17, 2021 | Articles | 0 comments

Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is registered under the ticker NASDAQ:VRPX . Check out our VRPX stock analysis, current VRPX quote, charts, and historical prices for Virpax Pharmaceuticals Inc stock The Company is focused on developing pharmaceutical product candidates for pain management by developing and delivering non-opioid and non-addictive pharmaceutical products. Get the hottest stocks to trade every day before the market opens … Virpax Pharmaceuticals (VRPX) stock price, charts, trades & the US's most popular discussion forums. WEST CHESTER, PA / ACCESSWIRE / February 19, 2021 / Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the closing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, … In depth view into Virpax Pharmaceuticals Preferred Stock explanation, calculation, historical data and more DUR-928 Alcoholic hepatitis. Which institutional investors are buying Virpax Pharmaceuticals stock? Virpax Pharmaceuticals, Inc. (VRPX) Stock Price: $4.02 USD -0.03 (-0.79%) Updated Jun 18, 2021 12:20 PM EDT - Market open. 09:00 AM ET. S&P 500 0.48%. VRPX Preferred Stock as of today (May 25, 2021) is $0.00 Mil. Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) stock closed at 4.62 per share at the end of the most recent trading day (a -5.33 % change compared to the prior day closing price) with a volume of 59.16K shares and market capitalization of 22.92M.Is a component of indices and it is traded on NASDAQ exchange. 10/09/2020. BUSINESS INQUIRIES. Find the stock by name or ticker symbol: VRPX. BERWYN, PA — Virpax Pharmaceuticals, Inc. ( NASDAQ: VRPX), announced its financial results for the quarter ended March 31, 2021, and other recent developments. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Feb 19, 2021 1:07 PM PST. Virpax Pharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Virpax Pharmaceuticals stock? Buy immediately with a market order or use a limit order to delay your purchase until Virpax Pharmaceuticals reaches your desired price. CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION . Virpax’s MMS019 Reduced Nasal and Brain Viral Load in Animal Study BusinessWire - BZX. The company belongs in the Biotechnology industry, Healthcare sector and … The company was founded by Anthony P. Mack on May 12, 2017 and and is … SCoRE: 63 . With Virpax Pharmaceuticals stock trading at $6.45 per share, the total value of Virpax Pharmaceuticals stock (market capitalization) is $29.08M. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Virpax Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Virpax Pharmaceuticals's VRPX shares and potentially its market environment have … $4.3301. Virpax Pharmaceuticals' lock-up period expires on Monday, August 16th. Virpax Pharmaceuticals had issued 1,800,000 shares in its initial public offering on February 17th. The total size of the offering was $18,000,000 based on an initial share price of $10.00. Virpax Pharmaceuticals stock was originally listed at a price of $6.53 in Feb 17, 2021. VIRPAX PHARMACEUTICALS, INC. Buy. View VRPX historial stock data and compare to other stocks and exchanges. The company’s stock price has collected 7.95% of gains in the last five trading sessions. The major determining factor in this rating is whether the stock is trading close to its 52-week-high. WEST CHESTER, PA / ACCESSWIRE / February 19, 2021 / Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the closing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross … Virpax Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations. Find out which indices include the Virpax Pharmaceuticals Inc stock. Virpax Pharmaceuticals Inc Stock Ownership Add to Watchlist. View Virpax Pharmaceuticals stock trends here About VRPX Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Virpax Pharmaceuticals is now publicly available to trade under the ticker symbol VRPX . February 19, 2021 - 4:07 pm. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). The current P/S ratio for Virpax Pharmaceuticals as of May 19, 2021 is . Data is currently not available. Access our live advanced interactive Virpax Pharmaceuticals Inc stock chart. Stock Price Prediction: Update at 5:00pm EST FRIDAY. NASDAQ 1.10%. Trending now. VIRPAX PHARMACEUTICALS, INC. Pursuant to Section 242 of the General Corporation Law of the State of Delaware, Virpax Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: 1. Learn about the SCoRE. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is registered under the ticker NASDAQ:VRPX . Virpax Pharmaceuticals, Inc. Common Stock, also called Virpax Pharmaceuticals, is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Trading. 10/09/2020. Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. virpax(r) pharmaceuticals announces pricing of initial public offering.announced pricing of ipo of 1.8 million shares of its common stock at a public offering price of $10.00 per share. Its products include Epoladerm, OSF200, Probudur, NES100, PES200 and MMS019. Virpax Pharmaceuticals Inc. advanced stock charts by MarketWatch. The relative strength of a dividend stock indicates whether the stock is uptrending or not. VRPX is DOWN -31% since the begininning of the year. Free forex prices, toplists, indices and lots more. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) went up by 1.00% from its latest closing price compared to the recent 1-year high of $8.24. However, action by the FDA has been deferred due to COVID-19. UBX1325 Phase 1 initial data expected 1H 2021. SEC Filings provided by EDGAR Online, Inc. Prev Page Next Page. Covers 1,009,505 shares of common stock issuable under the Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan (the “2017 Plan”). Topical metered-dose spray. VRPX updated stock price target summary. Monday, April 05, 2021. Research its history to confirm it's a solid investment against your financial goals. Free forex prices, toplists, indices and lots more. Find the latest Virpax Pharmaceuticals, Inc. (VRPX) stock discussion in Yahoo Finance's forum. 09:00 AM ET. Their stock opened with $10.00 in its Feb 16, 2021 IPO. Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. LAST PRICE - 02:40pm VRPX is trading DOWN -$-0.25 or -5.3% from yesterday's close of $4.75. Virpax Pharmaceuticals, Inc. Common Stock, also called Virpax Pharmaceuticals, is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. 2.12 “Common Stock” means the Company’s Common Stock, par value $0.00001 per share. Here's how you can invest. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Contact Email Info@virpaxpharma.com. OF. Services. SEC Filings for Virpax Pharmaceuticals Inc. View institutional ownership trends for Virpax Pharmaceuticals. Virpax Pharmaceuticals (NASDAQ:VRPX) and Galmed Pharmaceuticals (NASDAQ:GLMD) are both small-cap medical companies, but which is the superior stock?We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings. The company’s stock price has collected 12.53% of gains in the last five trading sessions. Sell. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. This page contains information on users’ sentiments for the Virpax Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table. View today's stock price, news and analysis for Virpax Pharmaceuticals Inc. (VRPX). Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. Poziotinib Phase 2 cohort 3 data did not meet primary endpoint – 12/22/20. Let’s start up with the current stock price of Virpax Pharmaceuticals Inc. (VRPX), which is $5.14 to be very precise. The Stock rose vividly during the last session to $6.00 after opening rate of $4.63 while the lowest price it went was recorded $4.50 before closing at $4.62. Their latest funding was raised on Feb 16, 2021 from a Series C round. Press Release reported 1 hour ago that Virpax Announces Results of Probudur(TM) in Animal Study. Its products include DSF100, Probudur, Epoladerm and NES100. ACCESSWIRE +5.74%. Find the latest Virpax Pharmaceuticals, Inc. (VRPX) stock quote, history, news and other vital information to help you with your stock trading and investing. Nasdaq 100. Virpax Pharmaceuticals Inc. (VRPX) registered a 1.00% upside in the last session and has traded in the green over the past 5 sessions. Virpax Pharmaceuticals Inc (NASDAQ:VRPX) has raised a total of $20.4M in funding over 3 rounds. Real-time exchange rate quote of VIRPAX PHARMACEUTICALS INC. - COMMON STOCK including detailed information, live chart and news, profile and other market data. Financials. Company information for Virpax Pharmaceuticals Inc USD0.00001 share priceincluding general stock details, key personnel and important dates for your diary. Other Notable StockTweets About VRPX. Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania. Rolontis PDUFA date was 10/24/20. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Get the hottest s The stock’s 5-day price performance is 7.95%, and it has moved by 19.35% in 30 days. Monday, April 19, 2021. Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments. Stock quote and company snapshot for VIRPAX PHARMACEUTICALS INC (VRPX), including profile, stock chart, recent news and events, analyst opinions, and research reports. PRICE ACTION $4.50. The current price to book ratio for Virpax Pharmaceuticals as of May 28, 2021 is 2.37. Virpax Pharmaceuticals, Inc. is a biopharmaceutical company. Free forex prices, toplists, indices and lots more. Virpax Pharmaceuticals Engages Torreya Capital to Advise on Global Partnering Efforts BusinessWire - BZX. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross … documents---0.0012590885162354. Their stock opened with $10.00 in its Feb 16, 2021 IPO. Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals is a preclinical stage biopharmaceutical company focused on becoming a global leader in pain management by developing and delivering innovative non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. A high-level overview of Virpax Pharmaceuticals, Inc. (VRPX) stock. The Virpax Pharmaceuticals, Inc. stock price fell by -0.74% on the last day (Thursday, 17th Jun 2021) from $4.08 to $4.05.During the day the stock fluctuated 6.91% from a day low at $4.05 to a day high of $4.33.The price has been going up and down for this period, and there has been a -7.95% loss for the last 2 weeks. Check if VRPX has a Buy or Sell Evaluation. 2.13 “Company” means Virpax Pharmaceuticals, Inc., a Delaware corporation, and any successor thereto as provided in Section 16.8. View Virpax Pharmaceuticals, Inc. VRPX investment & stock information. Virpax has licensed a patented metered-dose spray system that delivers active pharmaceutical ingredients (API). Ticker: VRPX. Commissions Margin Rates Interest Rates Research and News Market Data Stock Yield Enhancement Program Other Fees. +0.2801 (+6.92%) DATA AS OF Jun 16, 2021 11:14 AM ET. Mr. Virpax Pharmaceuticals, Inc. (the “Registrant”) hereby incorporates by reference the description of its common stock, par value $0.00001 per share, to be registered hereunder contained under the heading “Description of Securities” in the Registrant’s Registration Statement on Form S-1 (File No. (VRPX) raised $15 million in an initial public offering (IPO) on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO. VRPX: Get the latest Virpax Pharmaceuticals stock price and detailed information including VRPX news, historical charts and realtime prices. With your account you will as well have access to charting tools, advanced order types, leveraged trading and 24-hour global client support. The company is focused on developing pharmaceutical product candidates for pain management. Search for Virpax Pharmaceuticals. Sorrento said it learned of Virpax through documents it filed with the Securities and Exchange Commission after the company completed a small initial public stock … Overview Earnings Dividend Ownership. For financial reporting, their fiscal year ends on December 31st. Top institutional investors include HN Saltoro Capital LP (0.55%). Virpax Pharmaceuticals' stock is owned by many different retail and institutional investors. VRPX 4.50 0.25 (5.26%) After your fiat currency strikes your account, you will be able to buy stock from Williams Companies (WMB). Purchase now or later. One share of VRPX stock can currently be purchased for approximately $3.97. How much money does Virpax Pharmaceuticals make? Virpax Pharmaceuticals has a market capitalization of $19.63 million. N/A. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. Virpax will utilize our drug delivery technologies to develop a pipeline of proprietary prescription candidates for commercialization. Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. VIRPAX PHARMACEUTICALS, INC. : News, information and stories for VIRPAX PHARMACEUTICALS, INC. | Nasdaq: VRPX | Nasdaq Virpax Pharmaceuticals Announces Closing of Initial Public Offering. ACCESSWIRE +5.74%. Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Nasdaq Listed. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) loss -5.26% – Is It right time to buy? Virpax Pharmaceuticals Announces Closing of Initial Public Offering. Virpax Announces Results of Probudur(TM) in Animal Study ACCESSWIRE. WEST CHESTER, PA / ACCESSWIRE / February 19, 2021 / Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in … S-1. This proprietary spray formulation delivers the API as a film and may lead to adhesion capabilities superior to those of transdermal patches, while maintaining comparable skin absorption capabilities to transdermal patches currently on the market. Anthony P. Mack has more than 25 years of experience in the pharmaceutical and finance industries. The stock spiked 1.00% in intraday trading to $4.75 this Thursday, 06/10/21, hitting a weekly high. Get the latest Virpax Pharmaceuticals Inc (VRPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. DOW 0.03%. Registration Statement. The Stock rose vividly during the last session to $5.22 after opening rate of $4.376 while the lowest price it went was recorded $4.2649 before closing at $4.41. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Insider buying vs selling Have Virpax Pharmaceuticals Inc insiders been buying or selling? April 9, 2021 Let’s start up with the current stock price of Virpax Pharmaceuticals Inc. (VRPX), which is $6.00 to be very precise. Virpax Pharmaceuticals, Inc. engages in developing pharmaceutical products for pain management by using new drug delivery systems. Virpax Pharmaceuticals, Inc. 1055 Westlakes Drive, Suite 300 Berwyn, PA 19312 610.727.4597 info@virpaxpharma.com JUN 11 02:40:13pm VRPX. Historical PS ratio values for Virpax Pharmaceuticals (VRPX) over the last 10 years. Selected key stats of Virpax Pharmaceuticals, Inc. (VRPX) including 10 year stock price and latest news. Virpax Pharmaceuticals, Inc. Common Stock (VRPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Virpax Pharmaceuticals (VRPX) stock price, charts, trades & the US's most popular discussion forums. Virpax Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Company profile page for Virpax Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information Thani Jambulingam: Director: 2021-02-17: 100: Their latest funding was raised on Feb 16, 2021 from a Series C round. Phone Number 610.727.4597. February 16, 2021 - 7:45 pm. Get the latest Virpax Pharmaceuticals, Inc. VRPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. WEST CHESTER, PA / ACCESSWIRE / February 16, 2021 / Virpax ® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, … Virpax Pharmaceuticals Inc 4.50 0.25 (5.26%) Virpax Pharmaceuticals Inc OTC Updated Jun 11, 2021 4:44 PM. VRPX Virpax Pharmaceuticals Inc — Stock Price and Discussion | Stocktwits. Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) went up by 12.44% from its latest closing price compared to the recent 1-year high of $8.24. Virpax Pharmaceuticals, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. BERWYN, Pa.--(BUSINESS WIRE)-- Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2021, and other recent developments.“We successfully completed our initial public offering (IPO) of 1,800,000 shares of our common stock in mid-February and immediately began our IND enabling … Share your opinion and gain insight from other stock traders and investors. Please refer to the Stock Price Adjustment Guide for more information on our historical prices. New Stock: Look Up. Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the results of an animal study model for MMS019, its anti-viral product candidate for respiratory viruses. By Noah Smith June 14, 2021 How have the shares performed? Virpax Pharmaceuticals (VRPX) stock price, charts, trades & the US's most popular discussion forums. Right now VRPX is $0.50 below high of day. Platforms APIs Margin Products Order Types Securities Financing Features in Focus Probability Lab Exchange Listings Sustainable Investing. Add to … Overview. VRPX Stock Price (NASDAQ), Score, Forecast, Predictions, and Virpax Pharmaceuticals, Inc. News. This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee The current RSI for VRPX stock in for the last two-week period is set at 58.51, with the RSI for the last a single of trading hit 66.87, and the three-weeks RSI is set at 53.13 for Virpax Pharmaceuticals Inc. [VRPX], while it was recorded at 5.08 for the last single week of trading.

Schumacher 750 Watt Power Inverter Manual, Used Industrial Ice Machines, Big South Baseball Standings 2021, Puff Pastry Pies Chicken, Johnson And Johnson Vaccine Appointment Las Vegas, Her Majesty The King Hatshepsut, Adidas Field Hockey Sticks For Forwards, Pensacola Bay Center Seating Capacity,

Articlesvirpax pharmaceuticals stock